Surveillance for dysplasia is necessary for patients with ulcerative colitis. CON: Surveillance for ulcerative colitis-associated cancer: Time to change the endoscopy and the microscopy

Fergus Shanahan, Rodrigo Quera

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Expenditure of finite health-care resources on practices that have unproven or dubious efficacy needs careful reconsideration. The influence of medicolegal considerations on this aspect of patient management is a reality that needs to be addressed. While improvements in endoscopic techniques such as chromoendoscopy are encouraging, conventional histologic analysis of biopsy samples is suboptimal. One approach-perhaps idealistic-would be to direct resources toward fundamental research and development of better molecular biomarkers of increased risk of colitis-associated cancer. In the meantime, we may have to rely on increased efforts at primary prevention and common sense.

Original languageEnglish
Pages (from-to)1633-1636
Number of pages4
JournalAmerican Journal of Gastroenterology
Volume99
Issue number9
DOIs
StatePublished - Sep 2004
Externally publishedYes

Keywords

  • Biological Markers
  • Colitis, Ulcerative
  • Colonic Neoplasms
  • Colonoscopy
  • Female
  • Humans
  • Incidence
  • Ireland
  • Male
  • Microscopy
  • Precancerous Conditions
  • Primary Prevention
  • Risk Assessment

Fingerprint

Dive into the research topics of 'Surveillance for dysplasia is necessary for patients with ulcerative colitis. CON: Surveillance for ulcerative colitis-associated cancer: Time to change the endoscopy and the microscopy'. Together they form a unique fingerprint.

Cite this